C. Christofillakis

Multicenter Phase II Study of Gemcitabine and Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Colorectal Cancer Patients Pretreated with 5-Fluorouracil plus Irinotecan

K. Syrigos, I. Boukovinas, N. Ziras, 2006, Oncology.

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First‐Line Treatment of Metastatic Triple‐Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group

D. Mavroudis, V. Georgoulias, E. Saloustros, 2017, Clinical breast cancer.

Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: a multicenter phase II trial.

S. Agelaki, V. Georgoulias, A. Kalykaki, 2007, Lung cancer.